Table 1.
Demographic and outcome details of all patients with RIF pain
| Control | COVID‐19 | P value | |
|---|---|---|---|
| Number of admissions | 97 | 75 | |
| Male:female (%) | 50:47 (52:48) | 43:32 (57:43) | 0.45 |
| Age, years (range) | 10 (2–16) | 10 (4–15) | 1 |
| Time from symptom onset to presentation, days (range) | 2 (1–10) | 4 (1–14) | 0.01 |
| Admission white cell count, ×109 cells per litre (range) | 7.8 (3.1–18.7) | 9.7 (2.6–26.6) | <0.01 |
| Admission C‐reactive protein, mg/L (range) | 10 (1–106) | 24 (1–299) | 0.04 |
| Admission ultrasound scan (%) | 36 (37) | 26 (35) | 0.75 |
| Negative diagnostic laparoscopies | 7 | 0 | |
| Diagnoses (%) | 0.013 | ||
| Non‐specific abdominal pain | 45 (46) | 21 (28) | |
| Viral illness | 27 (28) | 18 (24) | |
| Appendicitis | 10 (10) | 18 (24) | |
| Constipation | 9 (9) | 10 (13) | |
| Urinary tract infection | 6 (6) | 8 (11) | |
| Length of stay, days (range) | 1 (0–6) | 1 (0–10) | 1 |
| 30 day re‐admission (%) | 7 (7) | 7 (9) | 0.78 |